Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 51410-30-1
2. Catalin Sodium
3. Pirenoxine Sodium Salt
4. Sodium 1-hydroxy-5-oxo-5h-pyrido[3,2-a]phenoxazine-3-carboxylate
5. 95ju7urf64
6. Sodium;1,5-dioxo-4h-pyrido[3,2-a]phenoxazine-3-carboxylate
7. 5h-pyrido(3,2-a)phenoxazine-3-carboxylic Acid, 1-hydroxy-5-oxo-, Monosodium Salt
8. Sodium 1-hydroxy-5-oxo-5h-pyrido(3,2-a)phenoxazine-3-carboxylate
9. Clarvisan (tn)
10. Ncgc00167452-01
11. Einecs 257-181-6
12. Unii-95ju7urf64
13. Pirfenoxone Sodium
14. 1-hydroxy-5-oxo-5h-pyrido(3,2-a)phenoxazine-3-carboxylic Acid Sodium Salt
15. Dsstox_cid_26637
16. Dsstox_rid_81783
17. Dsstox_gsid_46637
18. Pirfenoxone Sodium Salt
19. Schembl1650064
20. Chembl2359957
21. Dtxsid1046637
22. Schembl11579562
23. Pirenoxine Sodium [mart.]
24. Pirenoxine Sodium [who-dd]
25. Bcp12124
26. Pirenoxine Sodium Salt [mi]
27. Tox21_112456
28. Akos015951393
29. Cas-51410-30-1
30. D08388
31. W-105897
32. Q27271800
33. (5-methyl-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanol
34. Sodium 1,5-dioxo-1,5-dihydro-4h-pyrido[3,2-a]phenoxazine-3-carboxylate
35. Sodium 1-hydroxy-5-oxo-5h-pyrido(3,2-a)(phenoxazine-3-carboxylate
36. 5h-pyrido(3,2-a)phenoxazine-3-carboxylic Acid, 1-hydroxy-5-oxo-, Sodium Salt (1:1)
| Molecular Weight | 330.23 g/mol |
|---|---|
| Molecular Formula | C16H7N2NaO5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 1 |
| Exact Mass | 330.02526561 g/mol |
| Monoisotopic Mass | 330.02526561 g/mol |
| Topological Polar Surface Area | 108 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 777 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Pirenoxine Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pirenoxine Sodium, including repackagers and relabelers. The FDA regulates Pirenoxine Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pirenoxine Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pirenoxine Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pirenoxine Sodium supplier is an individual or a company that provides Pirenoxine Sodium active pharmaceutical ingredient (API) or Pirenoxine Sodium finished formulations upon request. The Pirenoxine Sodium suppliers may include Pirenoxine Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Pirenoxine Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Pirenoxine Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pirenoxine Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pirenoxine Sodium GMP manufacturer or Pirenoxine Sodium GMP API supplier for your needs.
A Pirenoxine Sodium CoA (Certificate of Analysis) is a formal document that attests to Pirenoxine Sodium's compliance with Pirenoxine Sodium specifications and serves as a tool for batch-level quality control.
Pirenoxine Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Pirenoxine Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pirenoxine Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Pirenoxine Sodium EP), Pirenoxine Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pirenoxine Sodium USP).
LOOKING FOR A SUPPLIER?
